Skip to main content
Sunday, November 15, 2026Nov 15

States say they’ll keep lawsuits against Purdue on hold

In this April 2, 2018, file photo, a pharmacist in San Francisco poses for photos holding a bottle of OxyContin. In court papers filed in New York on Sunday, Sept. 15, 2019, Purdue Pharma, the drug's manufacturer, flied for Chapter 11 bankruptcy protection. (AP Photo/Jeff Chiu, File)
In this April 2, 2018, file photo, a pharmacist in San Francisco poses for photos holding a bottle of OxyContin. In court papers filed in New York on Sunday, Sept. 15, 2019, Purdue Pharma, the drug's manufacturer, flied for Chapter 11 bankruptcy protection. (AP Photo/Jeff Chiu, File)

State attorneys general with pending lawsuits against OxyContin maker Purdue Pharma and its owners are asking a federal bankruptcy judge to give them more time to continue negotiating.

A temporary freeze on their lawsuits expires this week. On Wednesday, the judge is to decide whether to halt them or issue another temporary stay that could last for months.

In a filing earlier this week, about two dozen attorneys general said they are making progress in their talks with Purdue over the nation’s opioid crisis and want a six-week extension.

The states, along with the District of Columbia, opposed a tentative settlement the company reached in September with two dozen other states and many of the local governments suing it. Purdue filed for bankruptcy protection as part of that deal.